Candel Therapeutics Inc.
CADL | NASDAQ
$11.75
+$0.54 (+4.82%)
Sep 22, 2026, 1:37 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -88.53M | -54.42M | -38.18M | -22.76M | -22.14M | -39.58M | -55.18M | -52.2M | -49.99M | -37.37M | -37.94M | -31.93M | -32.18M | -26.72M | -18.79M | -12.12M | -19.59M | -32.52M | -36.12M | -48.2M | -34.59M | -20.39M |
Depreciation & Amortization | 678K | 749K | 845K | 927K | 977K | 984K | 990K | 994K | 994K | 981K | 960K | 932K | 892K | 843K | 778K | 735K | 551K | 371K | 232K | 60K | 84K | 85K |
Stock-Based Compensation | 6.76M | 4.96M | 3.82M | 3.77M | 3.79M | 4.58M | 5.31M | 5.01M | 4.51M | 3.4M | 3.09M | 2.79M | 2.84M | 2.55M | 2.31M | 1.23M | 2.39M | 3.02M | 2.96M | 5.16M | 3.34M | 2.57M |
Other Working Capital | 4.67M | -1.55M | 1.39M | -1.37M | -1.49M | -69K | 531K | 1.16M | -671K | 342K | -570K | -1.52M | -1.62M | -2.29M | 1.28M | 2.21M | 2.03M | 1.18M | -1.55M | -1.64M | -469K | -246K |
Other Non-Cash Items | 17.02M | 539K | -6.98M | -14.84M | -12.36M | 6.61M | 21.51M | 16.37M | 14.74M | 1.39M | 729K | -2.75M | -3.11M | -8.09M | -15.78M | -21.82M | -13.35M | 3.38M | 11.59M | 20.2M | 11.98M | 487K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -416K | -560K | -560K | -560K | -144K | n/a | n/a | n/a | n/a | n/a | n/a | 4.55M | 4.55M | 4.55M |
Change in Working Capital | 8.04M | 447K | 2.19M | -659K | -171K | 203K | 346K | 1.2M | -702K | 288K | -525K | -2.19M | -2.58M | -2.77M | 71K | 2.2M | 2.72M | 1.1M | -876K | -2.17M | -366K | 207K |
Operating Cash Flow | -56.02M | -47.73M | -38.31M | -33.56M | -29.89M | -27.2M | -27.02M | -28.63M | -30.87M | -31.86M | -34.24M | -33.71M | -34.28M | -34.19M | -31.42M | -29.77M | -27.28M | -24.64M | -22.22M | -20.4M | -15.01M | -12.48M |
Capital Expenditures | -1.3M | -1.26M | -587K | -181K | -37K | -12K | -16K | -60K | -163K | -326K | -457K | -686K | -798K | -1.26M | -1.3M | -1.53M | -1.7M | -1.78M | -1.84M | -1.78M | -2.12M | -1.71M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20.64M | 20.64M | 20.64M |
Other Investing Acitivies | 27K | 27K | 27K | 27K | n/a | n/a | n/a | 20K | 20K | 20K | 177K | 157K | 157K | 157K | n/a | n/a | n/a | n/a | n/a | -6K | -6K | 14K |
Investing Cash Flow | -1.27M | -1.23M | -560K | -154K | -37K | -12K | -16K | -40K | -143K | -306K | -280K | -529K | -641K | -1.11M | -1.3M | -1.53M | -1.7M | -1.78M | -1.84M | 18.85M | 18.51M | 18.94M |
Debt Repayment | 5M | 2.5M | n/a | -10M | -10M | -10M | -9.17M | -6.67M | -4.17M | -1.67M | n/a | n/a | n/a | n/a | 19.91M | 19.91M | 19.91M | 19.91M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 36.23M | 36.48M | 36.73M | 704K | 965K | 1.71M | 1.69M | 1.2M | 1.1M | 105K | -121K | 36K | 36K | 58K | 64K | 28K | 71.38M | 71.69M | 71.8M | 71.83M | 474K | 601K |
Financial Cash Flow | 158.32M | 151.78M | 56.1M | 104.12M | 109.16M | 93.67M | 94.28M | 2.25M | 569K | -1.38M | -121K | 36K | 36K | 58K | 19.97M | 19.94M | 91.29M | 91.6M | 71.8M | 71.83M | 474K | 601K |
Net Cash Flow | 101.03M | 102.82M | 17.23M | 70.41M | 79.23M | 66.45M | 67.24M | -26.43M | -30.44M | -33.55M | -34.65M | -34.2M | -34.89M | -35.23M | -12.74M | -11.36M | 62.31M | 65.18M | 47.75M | 70.28M | 3.98M | 7.06M |
Free Cash Flow | -57.32M | -48.99M | -38.9M | -33.74M | -29.93M | -27.21M | -27.04M | -28.69M | -31.03M | -32.19M | -34.7M | -34.39M | -35.08M | -35.45M | -32.72M | -31.3M | -28.98M | -26.42M | -24.05M | -22.18M | -17.13M | -14.19M |
Adj. Free Cash Flow | -64.08M | -53.95M | -42.72M | -37.51M | -33.72M | -31.8M | -32.35M | -33.7M | -35.54M | -35.59M | -37.79M | -37.18M | -37.92M | -38M | -35.02M | -32.52M | -31.38M | -29.45M | -27.02M | -27.34M | -20.46M | -16.76M |
Maintenance CapEx | -771K | -733K | -587K | -181K | -37K | -12K | -16K | -60K | -163K | -326K | -457K | -686K | -798K | -1.26M | -1.3M | -1.53M | -1.7M | -1.78M | -1.84M | -1.78M | -2.12M | -1.71M |
Growth CapEx | -526K | -526K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -56.79M | -48.47M | -38.9M | -33.74M | -29.93M | -27.21M | -27.04M | -28.69M | -31.03M | -32.19M | -34.7M | -34.39M | -35.08M | -35.45M | -32.72M | -31.3M | -28.98M | -26.42M | -24.05M | -22.18M | -17.13M | -14.19M |
Add to Watchlist
Select watchlists to add or remove CADL